About us
Protein Technologies Ghent
Proteomics & biopharmaceutical protein production and delivery technologies
Who
Protein Technologies Ghent is a consortium of research groups from UGent and VIB, each with a long-standing reputation of expertise in their respective fields.
Centered around facilitating biopharmaceutical moiety discovery and development, the consortium integrates the assembled know-how from its members to accelerate the process of developing novel therapies against e.g. viral infections, microbial antibiotics resistance and cancer.
These efforts inherently go hand-in-hand with the development of new supporting technologies.
The consortium aims to grant access to these high-end solutions for other public institutions and the biotech & pharma-industry in Belgium and beyond.
We do this by investing actively in the development of these assets into products that live up to industry-standards and subsequently offering integrated services to our network, or out-licensing the technology overall.
If deemed viable, we may choose to create a spin-off company in order to create the best circumstances for that particular technology to flourish.
What
Research topics include
- Proteomics
- Protein interaction studies
- Recombinant (synthetic) protein production
- Structural protein biology
- Biopharmaceutical target discovery & therapeutic lead development
- Nanodelivery technology
How
Protein Technologies is supported by UGent TechTransfer and Flemish Institute for Biotechnology (VIB).